| Literature DB >> 27689726 |
Anne Loesche1, Jana Wiese1, Sven Sommerwerk1, Vivienne Simon1, Wolfgang Brandt2, René Csuk3.
Abstract
Drug repurposing (=drug repositioning) is an effective way to cut costs for the development of new therapeutics and to reduce the time-to-market time-span. Following this concept a small library of compounds was screened for their ability to act as inhibitors of acetyl- and butyrylcholinesterase. Picloxydine, an established antiseptic, was shown to be an inhibitor for both enzymes. Systematic variation of the aryl substituents led to analogs possessing almost the same good properties as gold standard galantamine hydrobromide. Copyright ÂEntities:
Keywords: Acetylcholinesterase; Bisbiguanides; Butyrylcholinesterase; Picloxydine
Mesh:
Substances:
Year: 2016 PMID: 27689726 DOI: 10.1016/j.ejmech.2016.09.051
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514